“Technological advancements, patient awareness, high disposable income and increased aged population are the key factors driving US diabetes market growth”, says RNCOS.
Noida, UP -- (SBWIRE) -- 09/17/2015 -- The new report by RNCOS by the name of "US Diabetes Market Outlook 2020", predicts that the diabetes market of US is estimated to reach an approximately value of US$ 29.32 Billion by 2020. The CAGR over the period of 2014-2020 will be around 8.3%. Currently, the diabetes market has been segmented into 3 segments, namely, anti-diabetic drugs, insulin delivery devices and glucose monitoring devices segment. There are a number of products from each of the above segments which are currently in the market and providing the maximum benefits to the patients suffering from diabetes or prediabetes.
Apart from those products, there are a number of anti-diabetic drugs, insulin deliver devices like insulin pens and glucose monitoring devices like continuous glucose monitors, which are being developed by companies such as Pfizer, GlaxoSmithKline, Roche, Medtronic Inc, Sanofi, Novo Nordisk, Eli Lilly and many more. These companies are developing the products either individually or in collaboration with each other. Efforts are also being made to develop new treatment options like artificial pancreas and islet cell transplantation. All these factors will definitely lead to the growth of the US diabetes market in the coming years.
Research Analysis & Highlights
This report is spread in over 80 pages and provides an in-depth research and rational analysis of the current status and future prospect of the US diabetes market. The report analyzes the market for various key players of this industry in detail. The market potential of the anti-diabetic products has been estimated. The patient profile analysis and cost implications of treatment have also been explained. The drivers and challenges of this market have also been briefly discussed. A brief analysis on the different segments of diabetes market- anti-diabetic drugs, insulin delivery devices and glucose monitoring devices has been done. The report also provides an insight into the latest trends of this market. Later in the report the various government initiatives to make the diabetes treatment available across all sections of society have also been listed down. In the end, key players in the diabetes care market have been discussed about.
Some of the report's key highlights include:
- Islet Cell Transplantation to Revolutionize Diabetes Treatment
- Discovery of Novel Drugs to Keep Diabetes in Control
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM778.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.